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Although testosterone has recently been discovered to play a role in the 
biological stress response, its exact function is unclear. With the increased number of 
annual deaths around the world being attributed to heart disease, it is important to 
discern how hormones like testosterone influence the magnitude of the cardiovascular 
stress response. It is also critical to acknowledge the possibility of biological and 
psychological factors that may moderate these differences, such as anxiety: a state of 
inner worry or uneasiness that may be present prior to stressor exposure. This 
experiment examined cardiovascular and autonomic responses to psychosocial stress in 
healthy males aged 18-45 (n .a. 120) that were either given exogenous testosterone or 
placebo before being subjected to a social-evaluative stressor. Individual levels of trait 
anxiety were used as a moderator of testosterone's effects to the stress response. Results 
showed no significant effects of exogenous testosterone on heart rate and heart rate 
variability, suggesting that testosterone does not play a direct role in modulating the 
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The Heart Problem  
Heart disease remains the leading cause of death for both men and women 
worldwide (CDC, 2015). In the United States alone, approximately 610,000 individuals 
die of heart disease each year – accounting for about 1 in every 4 deaths annually 
(CDC, 2015). It is theorized that psychological stress is a key mechanism in poor long-
term cardiovascular health including long-term, stressful experiences such as high-
effort/low-reward conditions in the workplace (Siegrist, 1996), as well as acute, 
emotionally stressful situations, as in the case of the recently discovered Takotsubo 
cardiomyopathy, also known as “broken-heart syndrome” (Virani et al., 2007). Thus, it 
is important to study the various factors that influence cardiovascular reactivity in 
stressful contexts – in other words, what affords human resistance to stress in certain 
situations, and what exacerbates it in others.   
Stress 
Stress can be defined as “the generalized, nonspecific response of the body to 
any factor that overwhelms, or threatens to overwhelm, the body’s compensatory 
abilities to maintain homeostasis” (Sherwood, 2012). Because such onsets of extraneous 
pressure are continuously present in everyday life, the human body has developed 
complex mechanisms to deal with the strain. In the case of the cardiovascular system, 
stress typically results in an increase in heart rate (HR) in order to provide the body with 
needed energy, oxygen, and nutrients to combat the stressor or run away from it. A key 




between the sympathetic and parasympathetic pathways of the nervous system 
(Appelhans & Luecken, 2006). Both the sympathetic and parasympathetic components 
play an antagonistic role towards one another: when at rest, HR is kept at a slower, but 
more variable rate under strong parasympathetic (vagal) influence. On the other hand, 
the parasympathetic nervous system will actively withdraw during stress to allow the 
sympathetic nervous system to take control and stimulate the heart, resulting in a faster, 
less variable HR (Sherwood, 2012). This measure of heart rate variability (HRV) 
indicates overall parasympathetic nervous system activity and acts as a proxy for the 
relative strength of vagal influence over the heart and the rest of the viscera.  
Repeated and prolonged activation of the stress response may in fact correspond 
to overall detriment of the heart itself, seen in increased HR and decreased HRV 
(Brosschot et al., 2005; Krantz & McCeney, 2002). Furthermore, the amount of 
parasympathetic activity may link to the tendency to externalize or internalize health 
problems related to stressful situations such as martial conflict (El-Sheikh et al., 2001), 
immune system functioning (Thayer & Brosschot, 2005), and mood and anxiety 
disorders (Thayer & Lane, 2000). Therefore, studying HRV as a component of the 
stress response allows examination of a reliable predictor for overall health. 
Hormones 
In addition to the autonomic nervous system, endocrine systems are also 
fundamental components of the body's response to stressors. Cortisol is released as part 
of the hypothalamic-pituitary-adrenal (HPA) axis response to stress in order to 
metabolize amino acids, carbohydrates, and lipids in the body to sustain the brain 




the principal stress hormone, recent primary literature has indicated that other hormones 
may modulate stress responses as well. Testosterone, a hormone usually associated with 
both physical and behavioral traits of masculinity, may in fact play a role in the 
regulation of the stress response, either by modulating the endocrine response to stress 
directly (Rubinow et al., 2005) or by altering the psychological response to the stressor 
(Josephs et al., 2003). However, previous studies have not tested to what extent 
testosterone impacts cardiovascular responses to social stress, and if so, whether 
testosterone will increase or decrease these responses.  
There is evidence that basal testosterone is related to cortisol increases after a 
stressor related to status threat, for example after experiencing defeat in a dominance 
contest. High testosterone men who lost in a dog agility competition rose in cortisol, 
and low testosterone men experienced no difference in cortisol change regardless of 
winning or losing (Mehta et al., 2008). In a rigged videogame competition, post-contest 
increased cortisol levels were associated with high levels of basal testosterone among 
losers (Zilioli et al., 2013). At least in regards to competition stress, these studies point 
to a relationship between testosterone and increased stress reactivity. 
On the other hand, there is evidence in both non-human animals and humans for 
the opposite pattern. Recent research on acute, social-evaluative stress revealed that 
basal levels of testosterone predicted reduced cortisol response (Stephens et al., 2015). 
Similarly, testing acoustic startle reflex and skin conductance responses in women after 
administration of testosterone or placebo showed that exogenous testosterone buffers 
the stress response, rather than boosts it (Hermans et al., 2007). Stimulated cortisol 




replacement in corticotropin-releasing hormone (CRH) stimulation tests during gonadal 
suppression (Rubinow et al., 2005). As it stands, classifying testosterone as a buffer or a 
promoter to the stress response remains open for debate.  
Anxiety 
Despite this present ambiguity, it may be possible that various psychological 
components of stress moderate testosterone’s functional relationship to stress. A strong 
contender for this role is anxiety. According to the DSM-V, anxiety is “the anticipation 
of future threat” (American Psychiatric Association, 2013), resulting in general 
nervousness and unease. The degree to which an individual perceives an incoming 
situation as stressful – due in part to one’s anxiety levels – may moderate testosterone’s 
influence on the cardiovascular stress response.  
On a biological level, neurons in certain parts of the brain are highly attuned to 
changes in the environment that the individual may or may not need to fear. Of note, the 
amygdala – the part of the brain often associated with fear – and the hippocampus – the 
part of the brain associated with processing environmental information as well as 
memory – are particularly sensitive to these anxiety fluctuations (Leuner & Shors, 
2013). Furthermore, testosterone may interact with these brain areas that underlie 
anxiety, such as modulating amygdala reactivity (van Wingen et al., 2009). During an 
onset of anxiety, changes in synaptic plasticity at these regions facilitate the traits 
generally coupled with an anxiety attack. In other words, anxiety can be perceived as a 
preemptive response to a stressful event. This form of anticipation may then play a role 




Furthermore, the vagus nerve may play a role in anxiety due to its substantial 
role in feeding information back into the brain. Eighty percent of the vagus nerve fibers 
are afferent (Berthoud & Neuhuber, 2000), feeding critical information on the current 
physiological state of the body back to brain. The vagal mediated feedback results then 
in a cascade of mechanisms and subsequent physiological changes built to cope until 
the stress subsidies. As the vagus nerve feeds information to the brain about a possible 
stressor, an individual may take register of the physiological changes produced in 
response, such as increased HR (Bechara & Naqvi, 2004). Thus the vagus nerve may 
underlie the conscious experience of one’s internal physiological state – called 
interoceptive awareness – that can be a component of clinically-significant anxiety 
(Thayer & Ellis, 2010; Dunn et al., 2010). By studying the HRV responses as it relates 
to anxiety, the results obtained may prove useful for both medical and psychological 
clinicians.  
Although previous studies have not found anxiety to directly predict 
cardiovascular stress responses (Filová et al., 2015; Girlder, et al., 1997), testosterone 
could moderate this effect due to its own relation to the cardiovascular system (Norman 
et al., 2015). Experimental data suggests that self-reported levels of anxiety may in fact 
play a role in the interactions between stress hormones (like cortisol) and the 
cardiovascular system. Upon performing mental math tasks, student state anxiety scores 
were significantly correlated with recovery from the stressor, whereas their trait anxiety 
scores were significantly correlated with their resting period (Dimitriev & Saperova, 
2012). Thus, it is important to explore whether or not anxiety levels act to moderate this 




The Cardiovascular System & ECG 
 
Figure 1. ECG Waveform.  
The three major forms of note are the P wave, QRS complex, and the T wave. The P 
wave shows atrial depolarization of the subject heart, the QRS complex shows 
ventricular depolarization, and the T wave shows ventricular repolarization (Sherwood, 
2012). Image was taken from Ashley E.A., & Niebauer J. (2004). Chapter 3: 
Conquering the ECG. Cardiology Explained. London: Remedica. 
Whether or not testosterone or anxiety holds direct relevance in the stress 
response, natural resistance to stress can be greatly attributed to the nature of the human 
cardiovascular system itself. The cardiovascular system is a vital component of the 
human body: the pumping of blood distributes oxygen and removes carbon dioxide 
while allowing other nutrients to be delivered to where they are needed (Sherwood, 
2012). In addition, the heart also assists in maintaining homeostasis through regulation 
of blood temperature and salinity (Sherwood, 2012). Overall activity of the heart can be 
measured by an electrocardiogram (ECG), in which electrical currents generated by 
heart tissue depolarization and repolarization can be surmised in a few simple 




comparing time between each waveform as well as the frequency of each consecutive 
complex to normal rates and rhythms, a trained medical expert can identify any 
abnormalities that may lead to heart complications. 
Purpose 
Despite these correlations between hormones, stress, and cardiovascular 
responses to stress, whether or not testosterone acts almost exclusively as an enhancer 
or buffer of the cardiovascular stress response remains to be seen. Thus, this experiment 
investigated causal routes for exogenous testosterone’s negative or positive effect on 
stress-induced situations, in addition to anxiety levels as a possible biopsychosocial 
moderator of the cardiovascular response to stress. Experimental results will elucidate 
possible interactions between hormonal and cardiovascular systems in stressful 









The sample pool consisted of 120 healthy male participants between the ages of 
18 and 45 years old, as part of the “Effects of Testosterone on Human Social Behavior 
and Decision-Making” Protocol. Before enrollment, each participant was screened for 
physical or mental health issues. Informed consent was obtained at screening and at the 
time of their experimental session. 
Protocol 
The experimental protocol for each participant lasted approximately six hours, 
and was broken into two major sections: the morning and afternoon section, which was 
separated by a short lunch break. During the first section, consent forms were signed 
and baseline cardiovascular activity was recorded for five minutes while the participant 
rested in an individual testing room.  
Androgel Application  
The participant was then treated with either testosterone or placebo. 
Testosterone was administered in the form of Androgel, an FDA-approved trans-dermal 
topical gel used for treatment of male hypogonadism. The 162-mg dose was chosen by 
consultation with collaborators, under approval from the study’s medical advisor1. The 
placebo consists of a gel composed of the same Androgel ingredients with exception of 
the active testosterone ingredient. Application of the gel was carried out by the gloved 
                                                        





participant on two sites: the shoulders and upper arms, with a drying time of between 
one and five minutes (Fig 2). 
 
Figure 2. Androgel Application Model. 
Blue shaded areas represent sites of Androgel/Placebo application to be administered 
by the participant with assistance.  
Approximately half of the participants received Androgel, whereas the other half 
received placebo. Within each of these two groups, half were informed as to which 
product they received, whereas the remaining half were only told they had an equal 
chance to be given either the Androgel or the placebo. However, in all situations, 
experimenters did not know which group the participant has been placed into until the 
conclusion of the entire study. These single- and double-blind conditions were 
implemented to stringently control experimenter bias during data analysis and to be able 
to control for the participants’ expectancy effects – the expectation of a given result 





The Trier Social Stress Test 
Approximately 4 hours and 40 minutes after baseline recording, participants 
were introduced to the Trier Social Stress Test (TSST), a laboratory procedure that 
induces an acute stress response in the participant (Kirschbaum et al., 1993). The TSST 
consists of a mock job interview speech and performing mental math in front of a panel 
of two observers posing as specialists. Participants were given ten minutes alone to 
prepare a five-minute speech as to why he was the most qualified individual for a 
managerial job on campus (Appendix A). 
 After the preparation period, participants gave their speech in front of the panel. 
The panel was instructed to act as neutral to the participant as possible in order to keep 
the situation constantly stressful across all participants. After the five-minute period, the 
participant immediately proceeded to a serial subtraction math task in which 
participants repeatedly subtracted 13 from 6233. If they said an incorrect number, they 
had to start over from the beginning. A script was given to each member of the panel for 
procedure uniformity (Appendix B). After the participant completed the TSST, the 
participant was escorted back to his initial testing room, where he sat passively for a 10-
minute recovery period. 
Cardiovascular Data 
Cardiovascular activity was measured in the morning at baseline (ten minutes 
before the gel was applied) and for the entire duration of the TSST, with data being 






Cardiovascular functioning for the entire experiment was recorded with a 
BioPac MP150 Data Acquisition system non-invasively through the use of seven 
disposable biosensors attached to the participant. Three of the biosensors were used for 
ECG recording: placed on the right clavicle, the lower left abdominopelvic quadrant 
and the lower right abdominopelvic quadrant (Fig 3).  
 
Figure 3. BioPac Sensor Placement. 
Used for in-lab physiological measures. 
During measuring periods, HR and high frequency HRV were measured 
continuously with the BioPac MP150 wireless unit, then averaged across 1-minute 
increments – this was done to make sure an equal amount of values were obtained for 
each participant. HR was recorded as the number of beats per minute (bpm). HRV was 
characterized by the high-frequency (HF) component (0.15-0.4 Hz) of the auto-
regressive, power-spectral analysis of the participant’s cardiovascular waveform. This 
HF output of HRV is strongly correlated with vagal input (Kamath & Fallen, 1993), 
making it a useful index of parasympathetic activity. This data was reported using 
normalized units, allowing for statistical analyses that assume normal distribution of 







Figure 4. Timeline of Experimental Procedure. 
Duration denotes ECG recording time. Bottom units are in minutes, with + denoting 
minutes after recording of baseline HR and HRV.  
Anxiety 
We examined the results of the Spielberger State-Trait Anxiety Inventory 
(STAI) (1983). Experimental medians were used to assign both high and low state/trait 
anxiety groups. The numeral results were then used to test the extent to which trait 
anxiety scores moderated the impact of the testosterone manipulation on cardiovascular 
stress responses. Based on a 4-point Likert scale, the STAI uses 40 self-reported 
questions to measure state anxiety (Appendix C) – levels of anxiety at a given moment 
– as well as trait anxiety (Appendix D) – personal levels of overall anxiety.  
Data Analysis  
Data was cut using ACQKnowledge to the specific durations for all four epochs: 
Baseline, Prep, TSST, and Recovery (Fig 4). Kubios HRV was then used to clean 
artifacts and separate each file into one-minute samples for all epochs. SPSS Statistics 
(Version 23, 2015) was used for analyses. Averages for HR and HRV as well as 
standard error were derived for each individual epoch.  
HR and HF HRV data were subjected to separate 4 (Epoch) × 2 (Testosterone 





blinding assignment. To test interactions between testosterone/placebo and anxiety, the 
self-reported state and trait anxiety measures were entered as a continuous variable in 
repeated measures analyses, producing separate 4 (Epoch) × 2 (T/P) × continuous 
(anxiety) repeated measures GLMs for HR and HF HRV. 
In order to control for departures from sphericity, a Huynh-Feldt correction was 
applied when ε > 0.75 and a Greenhouse-Geisser correction was applied when ε < 0.75 
(Girden, 1992). Within-subject effects were subsequently analyzed. Degrees of freedom 
were reported for all interactions, and statistical significance was assigned as α = 0.05, 
with p < α considered significant. Lastly, eta-squared values (η2) were used to measure 








Measure N 1 2 3 4 5 
1. Testosterone (1) 
vs. Placebo (0) 
120 1.000     
2. Baseline HR 115 -0.097 1.000    
3. Baseline HRV 115 0.114 -0.445** 1.000   
4. Trait Anxiety 119 0.005 0.084 -0.042 1.000  
5. State Anxiety 120 0.040 0.000 -0.015 0.594** 1.000 
 
Table 1. Correlations between Measures.  
Numeral values represent Pearson Correlation coefficients r, with positive/negative 
values representing a positive/negative correlation. The closer r = 0, the less closely the 
measures are related. ** indicates a significant correlation. 
Preliminary Results  
Several participants did not have baseline cardiovascular activity recorded (n = 
3) due to equipment failure or because the data was too noisy to be scored (n = 2). Also, 
one participant neglected to answer the trait anxiety portion of the STAI (n = 1).  
One hundred twenty male participants (Mean age = 21.55, SD = 3.49, range = 
18-39) were used in total for the study.  Significant correlations were observed between 
Baseline HR and HRV (Table 1), which is consistent with prior research (Mangin et al., 
1998). Additionally, a significant positive relationship was observed between state and 
trait anxiety levels (Table 1), also in line with previous research that utilized the STAI 
(Fadaei et al., 2011). Thus, the experimental procedure was confirmed to have a strong 
working measure for obtaining accurate cardiovascular data as well as individual 





Effect of Testosterone on Heart Rate  
A main effect of time was found on HR, indicating that the onset of the social-
evaluative stressor related to an expected increase in HR (F(1.83,184.98) = 170.280, p < 
0.001, η2 = 0.628). Examining the Time × Androgel/Placebo coefficient revealed no 
significant differences in HR response to TSST between administration of Androgel or 
placebo (F(1.83,184.98) = 1.250, p = 0.287, η2 = 0.012) (Fig 5A). This indicates that 
testosterone does not increase or decrease the cardiovascular stress response. 
Participants in the testosterone group on average experienced an increase in average HR 
from Baseline (M = 68.651, SD = ±9.360) to TSST (M = 87.504, SD = ±13.817) with a 
drop to near-baseline levels during Recovery (M = 69.103, SD = ±9.801) (Fig 5A). This 
trend was also observed in the placebo group, with average HR increasing from 
Baseline (M = 72.152, SD = ±9.342) to TSST (M = 87.853, SD = ±13.558) followed by 
a decrease during Recovery (M = 70.429, SD = ±9.705) (Fig 5A). These outcomes 
suggest that testosterone does not play a significant role in moderating HR changes 
during exposure to a stressor. 
Effect of Testosterone on Heart Rate Variability 
A main effect of time was found on HRV, indicating that the onset of the social-
evaluative stressor related to an expected increase in HRV (F(2.79,282.32) = 19.127, p 
< 0.001, η2 = 0.159). A significant difference was observed in HF HRV response to 
TSST between Androgel and placebo (F(2.80,282.31) = 2.911, p = 0.038, η2 = 0.028), 
though this is likely a spurious result as Androgel was found to increase HF HRV to the 
greatest degree during Baseline (M = 38.414, SD = ±13.618) in comparison to placebo 





was run with the latter three epochs controlling for individual baseline HRV. In this 
model, the Time × Androgel/Placebo was reported to be null (F(2,200) = 0.997, p = 
0.371, η2 = 0.01) (Fig 5B). Given that the testosterone vs. placebo gel had not been 
applied prior to collecting this data, it is unlikely that this effect extends causally from 
increased testosterone concentration. Additionally, these elevated levels of HF HRV 
were only seen during Baseline and Prep, as both TSST and Recovery yielded lower 
average levels of HF HRV in the testosterone group (TSST: M = 28.791, SD = ±10.344; 
Recovery: M = 38.220, SD = ±13.984) compared to placebo (TSST: M = 30.809, SD = 
±10.010; Recovery: M = 38.408, SD = ±12.897) (Fig 5B). Thus, although a significant 
relationship was observed between testosterone and HF HRV, since the differences are 
most evident during pre-stressor exposure, results make it hesitant to interpret this as a 
significant effect of testosterone’s moderating influence on the parasympathetic 
response to social stress.  
State Anxiety 
State anxiety scores were recorded by the participants with the STAI, with the 
self-report recorded in the morning session. First, statistical analysis tested whether or 
not state anxiety predicted differences in physiological response to the stressor. 
Examination of the 4 (Time) × continuous (STAI – State) interaction term revealed no 
main effect (F(1.85,187.08) = 2.805, p = 0.067, η2 = 0.027). Again employing a 
repeated-measures GLM – this time a 4 (Time) × 2 (T/P) × continuous (STAI – State) – 
once again showed no significant effects on either the HR (F(1.90,180.92) = 0.189, p = 





interaction (Fig 6A; 6B). Based on these outcomes, individual state anxiety played no 
role in moderating testosterone action on HR or HF HRV.  
In order to confirm the observed results, interactions between different anxiety 
levels across each participant was examined. High and low state anxiety was assigned 
using the median STAI score (= 31), with scores > 31 signifying high levels of state 
anxiety. State anxiety during the morning session was not found to be a significant 
moderator of the HR response to social stress (F(1.90,188.38) = 0.608, p = 0.538, η2 = 
0.006) (Fig 6A). Similarly, interactions between average HF HRV, in each epoch, 
testosterone vs. placebo, and levels of state anxiety were not statistically insignificant 
(F(2.85,282.13) = 0.176, p = 0.905, η2 = 0.002) (Fig 6B). As such, results suggested that 
the effects of testosterone on HRV were not moderated by individuals’ state anxiety. 
Trait Anxiety  
Trait anxiety scores were also recorded by the participants with the STAI during 
the morning session. No significant main effect between 4 (Time) × continuous (STAI – 
Trait) was observed (F(1.82,187.48) = 0.395, p = 0.655, η2 = 0.004), suggesting that 
trait anxiety did not predict any differences in cardiovascular response upon exposure to 
the stressor. Additional GLMs on 4 (Time) × 2 (T/P) × continuous (STAI – Trait) effect 
on HR also yielded nonsignificant moderation (F(1.89,177.68) = 0.325, p = 0.711, η2 = 
0.003) (Fig 7A), a result also observed in HF HRV (F(2.68,251.90) = 0.272, p = 0.824, 
η2 = 0.003) (Fig 7B). Similar to state anxiety results, this suggests that personal levels 
of anxiety do not moderate HR or HF HRV in regards to the effects of testosterone.  
As with state anxiety measures, high and low trait anxiety was assigned using 





Examining the HR interaction term for epoch, trait anxiety, and T/P groups revealed 
statistically insignificant results (F(1.85,181.38) = 0.874, p = .412, η2 = 0.009) (Fig 7A), 
suggesting no link between trait anxiety and any testosterone-HR interaction. Similarly, 
the Time × T/P × Trait anxiety interaction was also determined to be statistically 
insignificant (F(2.85, 279.74) = 0.253, p = .850, η2 = 0.003) (Fig 7B). Thus, underlying, 
long-term anxiety does not seem to significantly moderate cardiovascular activity, 
ruling out anxiety as a psychological moderator of testosterone’s effects on the HF 







Figure 5. Average HR & HF HRV. 
Heart data recorded with BioPac MP150 and processed with Kubios HRV. A. Average 
HR (bpm) recorded across all four epochs for both Placebo and Testosterone groups. B. 
Average HRV recorded across all four epochs for both Placebo and Testosterone 






























































Figure 6. State Anxiety. 
Heart data recorded with BioPac MP150 and processed with Kubios HRV. Low state 
anxiety determined by STAI state score < 31. A. Average HR (bpm) recorded across all 
four epochs for both Placebo and Testosterone groups. B. Average HRV recorded 
across all four epochs for both Placebo and Testosterone groups. Error bars represent 



































































Figure 7. Trait Anxiety.  
Heart data recorded with BioPac MP150 and processed with Kubios HRV. Low trait 
anxiety determined by STAI state score < 38. A. Average HR (bpm) recorded across all 
four epochs for both Placebo and Testosterone groups. B. Average HRV recorded 
across all four epochs for both Placebo and Testosterone groups. Error bars represent 



































































HR & HRV 
The present experiment aimed to clarify whether or not heightened levels of 
testosterone acted as buffer or enhancer of the cardiovascular stress response. In 
contrast to prior evidence suggesting that testosterone may either buffer or boost stress 
responses, there were nonsignificant effects of testosterone compared to placebo 
treatment on HR and HRV responses to the social-evaluative stressor. There were also 
nonsignificant interactions between self-reported anxiety and testosterone treatment on 
cardiovascular stress responses. Although these null effects of testosterone on the 
cardiovascular stress response was not anticipated, they cannot be due to a failure of the 
stressor to induce cardiovascular changes. Indeed, there were robust increases in HR 
(and reductions in HRV) during the stressor. Other analyses from the overarching study 
– which were outside the scope of this experiment – revealed that testosterone treatment 
led to increased cortisol changes during the stressor compared to placebo treatment 
(Data not shown). Thus, it seems that exogenous testosterone selectively impacted one 
component of the stress response – cortisol – but had no direct influence on 
cardiovascular responses to the stressor.   
It is possible that the usage of Androgel limited the pool of participants solely to 
males. Other independent research concerning stress has used both males and females. 
This is of particular importance since prior social-evaluative stress experiments revealed 
that females exhibited greater stress-related HR increases compared to males (Kudielka 





faced with a laboratory stressor: women were observed to act more as “cardiac” reactors 
in comparison to men, who were considered “vascular” reactors (Allen et al., 1993). 
Because only males were subjected to the TSST in this study, null effects may have 
been due to neglecting the changes in systolic and diastolic blood pressure responses in 
favor for cardiovascular responses. Thus, given these sex-based differences in 
laboratory stress responding, it may be of interest for future research to include both 
men and women when studying the causal effects of testosterone on the cardiovascular 
responses to stress. Inclusion of blood pressure measurements would also provide an 
additional variable to check for possible interactions.  
Another possibility that could account for the null results in the present 
experiment deals with the age group. Aggregated TSST results revealed a significant 
age-related decline in HR upon psychosocial stressor exposure, with greater increases 
correlating with children and younger adults (Kudielka et al., 2004). Conversely, 
responses to daily stressors were not different between younger adults (Mage = 20) and 
older adults (Mage = 80) (Stawski et al., 2008). Because the majority of participants in 
the study were younger adults, this could have explained the similar increased HR 
readings across epochs. Further experimentation using cardiovascular activity from a 
narrower age sample or across different age groups will help to confirm whether or not 
age actually plays a role in the cardiovascular stress response and any testosterone 
interactions.  
Lastly, experimental results were strictly derived from whether or not 
testosterone levels were heightened with Androgel, or unchanged with placebo. 





testosterone levels – individual inherent amounts of testosterone in the body – were 
collected but were not considered between each participant in the present report. Basal 
testosterone levels have been shown to correlate with other forms of stress physiology, 
including cortisol under competition conditions (Mehta et al., 2008; Zilioli et al., 2013) 
and cortisol reactivity to social-evaluative stress (Stephens et al., 2015). If basal 
testosterone levels between each individual in this study were greatly different, 
experimental results may have been skewed.  
Looking at the experimental design, the procedures were part of a far larger 
procedure that lasted a total of around 6 hours per participant. It is possible that the 
large gaps of time before, between, and after each cardiovascular recording period had a 
significant impact on how the acute stressors were handled by each participant. In 
addition, the nature of the various tasks carried out by the participant before the TSST 
necessitates consideration. Several tasks were carried out by the participant before the 
TSST, in addition to a lunch-break and instruction-giving periods. These tasks could 
have either heightened or decreased the observed individual stress response during the 
Prep and TSST epochs, as the participant may have been tired out by the day’s prior 
tasks. This, in turn, may have left subjects more vulnerable to a social stressor such as 
the TSST, or possibly even less responsive due to exhaustion. An independent, focused 
experiment on the relationship between exogenous testosterone and the cardiovascular 
stress response may provide cleaner experimental setting to test the nature of the 





Effects of Anxiety  
In this experiment, anxiety was used as a psychological moderator to check for 
any intermediate controllers between testosterone and cardiovascular activity. Using 
self-reported measures of state and trait anxiety did not moderate the effect of 
testosterone vs. placebo on cardiovascular reactivity to stress. Similarly, varying levels 
of state anxiety yielded no statistically significant results. This was consistent with 
previously observed studies (Filová et al., 2015; Girlder, et al., 1997). The present work 
extends these findings by showing that heightening individual levels of testosterone 
exogenously does not interact with self-reported anxiety to alter the cardiovascular 
stress response.  
These results raise the question of whether or not there are other, more important 
variables that may more clearly interact with testosterone levels to alter the 
cardiovascular stress response. One such variable is positive and negative affect – 
subjective experiences of pleasant or unpleasant emotions, respectively. Upon exposure 
to a speech task, adolescent females reported higher negative affect and increased 
baseline HR in comparison to adolescent male participants (Steiner et al., 2002). If an 
individual harbors a greater degree of general emotional negativity, they may be more 
prone to any effects testosterone has on HR and HF HRV. Again, the gender differences 
seen in this study suggest that the null results could be due to only males being 
examined. As such, focusing on a broader sense of positivity or negativity for a person’s 
current emotional state may hold greater value than anxiety when examining 





Another possibility that could link testosterone and cardiovascular reactivity is 
social status – one’s standing in a group or society. Testosterone and social status have 
been shown to be linked in some way – in higher status positions, individuals with 
higher levels of testosterone performed better on spatial and verbal tests and 
simultaneous blood pressure drops compared to those in a low-status position (Newman 
et al., 2005).  There is also evidence for mismatch: high testosterone levels in low status 
positions has been shown to predict increased stress reactivity and poorer performance 
(Josephs et al., 2003). Lower socioeconomic status has also been linked, increased risks 
for cardiovascular disease. In participants with a measured low grade of employment, 
exposure to performance tasks post-stress resulted in longer recovery times of 
cardiovascular activity to baseline (Steptoe et al., 2002). Based on these previous 
studies, it may be possible that low-status individuals are more prone to testosterone 
acting as an enhancer of the cardiovascular stress response. Because perceived levels of 
social status were not accounted for this experiment, any observed null relationships 
between testosterone and stress reactivity could have been due to this lack of 
consideration.  
Finally, it is worth noting that many of the experiments conducted on 
testosterone and the human stress response use cortisol rather than cardiovascular 
activity in order to measure reactivity (Demyttenaere et al., 1989; Mehta et al., 2008; 
Rubinow et al., 2005; Stephens et al., 2015; Zilioli et al., 2013). Thus, this experiment 
demonstrates that although testosterone does indeed play a role in the human stress 
response by influencing cortisol levels, the cardiovascular component of stress 





to explore multifaceted stress reactivity to be able to clearly state which aspects of the 
stress response are more and which are less dependent on testosterone. 
Conclusion 
The results of this experiment suggest that increasing levels of testosterone 
exogenously has no impact on the cardiovascular stress response, even though 
testosterone treatment increased cortisol responses to the stressor. Future research 
should focus on varying age groups and gender, in addition to exploring other possible 
biological or psychosocial moderators to see if any pathways still exist. Despite the lack 
of statistical significance, outcomes contained within this report will help encourage 
future important questions surrounding steroid hormones such as testosterone and their 
interplay with stress and cardiovascular health. In addition, the continued investigation 
of testosterone’s effects on stress holds much clinical merit, particularly in observing 
adolescent or younger individuals when the human body starts production of 
testosterone: The role (or lack thereof) that testosterone plays in the stress response 
during puberty – a time of great social, psychological, and biological change – is largely 
unknown. Discerning the relationship between testosterone and cardiovascular stress in 
this experiment will open new avenues for clinical research and possibly new 






Affect – The feelings of emotion; usually expressed in facial features and gestures.  
Afferent – Conducted towards the central nervous system (brain and spinal cord).  
Amygdala – Part of the brain that is responsible for the fear response.  
Anxiety – A psychological disorder characterized by nervousness.  
Buffer – Something that assists to lessen or moderate a given change. 
Cardiomyopathy – “Heart Muscle Disease”; any condition that involves the slow 
degradation of the heart and impedance of function.  
Cardiovascular – Pertaining to the heart. 
Cortisol – A steroid hormone released in the body to control stress. 
Degrees of Freedom – The amount of values from a reported calculation which are free 
to vary.  
Double-Blind – Experimental condition in which critical information that may 
influence tester or subject behavior is withheld until the end of said experiment.  
Effect Size – The strength of an observed relationship between two variables.  
Electrocardiogram – Instrument that uses electrical signals generated by the heart in 
order to monitor its activity.  
Epoch – A set division of time.  
Exogenous – On the surface.  
GLM – Generalized Linear Model; a generalization used for statistical analysis of 
variables that do not have a normal distribution.  





Hippocampus – Part of the brain that is the center of emotion, memory, and the 
autonomic nervous system.  
Homeostasis – A self-regulating process that involves keeping variables at an optimal 
level under different conditions.  
Hormone – A class of signaling molecules that regulate physiology and behavior.  
Hypothalamic-Pituitary-Adrenal (HPA) Axis – Endocrine gland complex in the body 
that controls various bodily processes, such as stress reactivity.  
Impedance Cardiography – Measuring technique used to examine a number of 
cardiovascular parameters over time.  
Interoceptive Awareness – Phenomenon in which an individual is conscious of the 
current inner state of his/her body.  
Moderator – Any factor that can alter the direction or magnitude of a given 
relationship between a set of variables.  
Normalized Units – Values that have been adjusted in order to bring distributions of 
measures into alignment for analysis.  
Parasympathetic Nervous System – Division of the autonomic nervous system that 
deals with the body’s “rest and digest” function. 
Pearson Correlation Coefficient – A measure of the linear correlation between two 
variables by assigning a value from -1 to +1.  
Placebo – A substance with no actual therapeutic benefit; often used in experiments to 
test the effectiveness of drugs.  
Single-Blind – Experimental condition in which critical information that may influence 





Social Status – The position an individual holds in society.  
Sphericity – An assumption held by ANOVAs that assumes variance of difference 
between all independent variables are even.  
State Anxiety – Anxiety of an individual based on current circumstances.   
Steroid – A class of organic compound, many of whom act as signaling molecules.  
Stress – The body’s response to any threat that may disrupt homeostasis.  
Stressor – Any agent that induces stress upon an individual.  
Sympathetic Nervous System – Division of the autonomic nervous system that deals 
with the body’s “fight or flight” function.  
Testosterone – The male sex hormone.  
Trait Anxiety – Anxiety of an individual based on personal levels.  
Vagus Nerve – Cranial nerve that connects and moderates parasympathetic control of 








Appendix A. Job Listing 
Seeking job candidate with managerial experience to supervise student-employees in an 
on-campus position at the University of Oregon, Division of Student Affairs Career 
Center.  
 
About the Career Center: The Career Center provides career and job search services 
and resources to UO students and alumni. Our mission is to help develop long-term 
career goals and strategies, facilitate self-exploration and discovery, connect with 
potential employers, and empower and challenge students and alumni to fulfill their 
potential. We serve as advocates to help others pursue an inspired and fulfilling future. 
 
Position: Parent Professional Network Manager 
 
Salary Range: $36,000-$60,000 per year, commensurate with applicant qualifications 
 
About the position: This is a managerial position that requires you to oversee up to 
twelve student-employees. You will make decisions regarding their daily tasks, evaluate 
your employees on their performance, and determine how to compensate the students 
for their work. You will report to the Career Center Director. The job additionally 
requires you to: 
 
• Design and manage the Parent Professional Network (PPN) program in support 
of UO student and alumni career and professional development 
 
• Recruit and provide outreach/support to parent and alumni professionals to 
engage them in the PPN program via participation in informational interviews, 
job shadowing, panels/ presentations, networking events, mentoring 
opportunities, recruitment and hiring, and/or other career related activities with 
UO students and alumni 
 
• Assess learning and program outcomes for program enhancements and 
program/ROI reporting 
 
• Collaborate widely with a diversity of program stakeholders for program 












Required Qualifications         
• Demonstrated experience in advising, consulting or professional customer 
service experience 
• Demonstrated supervision experience of paraprofessional or professional staff 
• Demonstrated experience with and/or commitment to working effectively with 
students, parents, faculty and staff from diverse backgrounds in support of the 
office’s goals 
 
Additional Required Qualifications 
• Demonstrated ability to work in a dynamic, highly collaborative, team-oriented 
environment 
• Demonstrated time management, follow-through and organizational skills 
• Demonstrated interpersonal, presentation skills as well as demonstrated ability 




































Appendix B. TSST Panel Instructions  
 
The Speech 
Experimenter introduces the participant to the panel and then leaves the room. The job 
listing is on the table. The panel then speaks to participant: 
As you know, you have 10 minutes to prepare a 5-minute speech on why you are 
the perfect applicant for the vacant position on campus. We are the panel in 
charge of hiring for this position; you will give your speech in front of us. The 
notepad and job listing is here to help you prepare for your speech but you will 
not be able to use them during the speech. Once we leave the room, you will 
have ten minutes to prepare.  
 
Panel leaves, start time once door closes. After ten minutes, Panel reenters the room 
and says: 
Time is up. Please hand me your notes.  
 
5 minute timing starts at end of these next instructions. Interviewer #1 states: 
Please stand on the X and begin when you are ready. We will tell you to stop 
after 5 minutes. 
 
If participant pauses for 15-20 seconds during the first 3 minutes, Interviewer #1 will 
say: 
 You still have some time left. Please continue.  
 
If after the first three minutes the participant stops talking and does not begin again 
after prompting (as above), OR if he states specifically that he has nothing left to say, 
the panel may ask the following questions. Use them sparingly and rely on silence to 
encourage the participant to continue speaking: 
 Tell us about a time you managed a project or a group of people. 
 We are interviewing 120 candidates for this job: Why should we hire you? 
 Tell me one thing you would change about your last job? 
 Tell me about your strengths & weaknesses. 
Tell me about a time when old solutions didn’t work. 
What’s the biggest risk you’ve ever taken? 
Describe a time when a team you were part of did not agree. 
 
If the participant doesn’t talk for very long after a question, wait a 5-10 seconds after 
the end of their response, then use one of the following: 
 Can you elaborate on that answer? 
 What else can you tell us about XXX? 
 
After 5 minutes, Interviewer #2 states the following: 






Interview #1 takes over and says: 
Now we would like you to subtract 13 from 6233 out loud, and keep subtracting 
13 from the remainder until we tell you to stop.  You should do the subtraction 
as fast and as accurately as possible. Please begin. 
 
If the participant doesn’t realize they are supposed to keep subtracting, Interviewer #1 
says: 
 Please continue subtracting 13 from your answer. 
 
Whenever the subject makes an error, Interviewer #1 says: 
That is incorrect.  Please start again from the beginning.  [Provide the number 
6233 again as necessary.] 
 
After 5 minutes, Interviewer #2: 



































Appendix C. STAI-State Form Y-1 
 
STAI-State Form Y-1 
Instructions:  A number of statements which people have used to describe themselves are given below. 
Read each statement and then choose the appropriate number to the right statement to indicate how you 
feel right now, that is, at this moment. 
 
1 = Almost Never 
2 = Sometimes 
3 = Often 
4 = Almost Always 
 
 
1.   I feel calm ............................................................................................................ 1     2     3     4 
2.   I feel secure ......................................................................................................... 1     2     3     4 
3.   I am tense ............................................................................................................. 1     2     3     4 
4.   I feel strained ....................................................................................................... 1     2     3     4 
5.   I feel at ease ......................................................................................................... 1     2     3     4 
6.   I feel upset ........................................................................................................... 1     2     3     4 
7.   I am presently worrying over possible misfortunes ............................................. 1     2     3     4 
8.   I feel satisfied ...................................................................................................... 1     2     3     4 
9.   I feel frightened ................................................................................................... 1     2     3     4 
10.  I feel comfortable ............................................................................................... 1     2     3     4 
11.  I feel self-confidant ............................................................................................. 1     2     3     4 
12.  I feel nervous ...................................................................................................... 1     2     3     4 
13.  I am jittery .......................................................................................................... 1     2     3     4 
14.  I feel indecisive................................................................................................... 1     2     3     4 
15.  I am relaxed ........................................................................................................ 1     2     3     4 
16.  I feel content ....................................................................................................... 1     2     3     4 
17.  I am worried ....................................................................................................... 1     2     3     4 
18.  I feel confused .................................................................................................... 1     2     3     4 
19.  I feel steady ........................................................................................................ 1     2     3     4 






































Appendix D. STAI-Trait Form Y-2  
 
STAI-Trait Form Y-2 
Instructions:  A number of statements which people have used to describe themselves are given below.  
Read each statement and then circle the appropriate number to the right of the statement to indicate how 
you generally feel. 
 
1 = Almost Never 
2 = Sometimes 
3 = Often 
4 = Almost Always 
 
 
1.   I feel pleasant ....................................................................................................... 1     2     3     4 
2.   I feel nervous and restless .................................................................................... 1     2     3     4 
3.   I feel satisfied with myself................................................................................... 1     2     3     4 
4.   I wish I could be as happy as others seem to be .................................................. 1     2     3     4  
5.   I feel like a failure ................................................................................................ 1     2     3     4 
6.   I feel rested .......................................................................................................... 1     2     3     4 
7.   I am “calm, cool and collected” ........................................................................... 1     2     3     4 
8.   I feel that difficulties are piling up so that I cannot overcome them.................... 1     2     3     4 
9.   I worry too much over something that really doesn’t matter ............................... 1     2     3     4 
10.  I am happy .......................................................................................................... 1     2     3     4 
11.  I have disturbing thoughts .................................................................................. 1     2     3     4 
12.  I lack self-confidence ......................................................................................... 1     2     3     4 
13.  I feel secure ........................................................................................................ 1     2     3     4 
14.  I make decisions easily ....................................................................................... 1     2     3     4 
15.  I feel inadequate ................................................................................................. 1     2     3     4 
16.  I am content ........................................................................................................ 1     2     3     4 
17.  Some unimportant thought runs through my mind and bothers me .................... 1     2     3     4 
18.  I take disappointments so keenly that I can’t put them out of my mind ............. 1     2     3     4 
19.  I am a steady person ........................................................................................... 1     2     3     4 
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